RadNet Posts Q1 Results: Revenue, Assets Up

Matthew Skoufalos | | Radiology Business | Business Intelligence
After a quarter of aggressive partnerships and acquisitions in early 2012, RadNet still posted a 17 percent increase in year-over-year revenues for the quarter, which totaled $168.5 million. Per-share net income for the quarter was flat, an improvement over Q1 2011 figures, when shares lost $0.02 apiece. The company numbers $626.3 million in assets for the quarter, up nearly two percent from year-ago assets of $619.2 million, against $111.1 million in total liabilities for the quarter, up eight percent from $103.1 in liabilities during the first quarter of 2011. Also in Q1, RadNet reported MRI volume was up 23.8 percent year-over-year, CT volume was up 23 percent, and PET/CT volume increased 14.6 percent. President and CEO Dr. Howard Berger said in a statement that the results were encouraging in what is typically a challenging quarter for the company. “We continued to execute on our operating plan of enhancing our regional market penetration and presence, driving operational efficiencies and broadening growth opportunities in our existing core markets,” Berger said.

Matthew Skoufalos

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.